Day: January 18, 2024

AviadoBio Announces Formation of Scientific Advisory Board

AviadoBio, a pioneering, pre-clinical stage, gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, announces that it has established a Scientific Advisory Board (SAB) [...]
Read more

CombiGene and Neurochase Preclinical Study

CombiGene’s and Neurochase’s preclinical study provides valuable information for the upcoming long-term studies in toxicology and biodistribution STOCKHOLM — On June 28, 2021, CombiGene (“CombiGene”, “the Company”) announced that the [...]
Read more
© 2024 Neurochase
Privacy Policy